New patent for Abbvie Inc drug QULIPTA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for QULIPTA
Annual Drug Patent Expirations for QULIPTA

Qulipta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

QULIPTA drug price trends.

This drug has eigthy-four patent family members in forty-one countries.

The generic ingredient in QULIPTA is atogepant. One supplier is listed for this compound. Additional details are available on the atogepant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top